Promoting Excellence in Symptom Management Case Series

The oral route is compromised for nearly all patients at the end of life (EOL). This article reviews the benefits and burdens of the usual alternative routes of medication delivery when the oral route fails and presents a case study on the use of a new innovation for the rectal delivery of medication to control EOL symptoms. A 62-year-old male hospice patient with end-stage metastatic prostate cancer presented with severe symptoms (Face, Legs, Activity, Cry and Consolability scale score, 9/10) that were uncontrollable with medications given via oral or sublingual routes. The patient goals were to remain at home with optimal symptom management. Rapid relief of symptoms was accomplished by the administration of medications already present in the home delivered with a new rectal catheter that provides discreet access for ongoing medication administration. Significant relief was noted within 20 minutes of dosing. The patient died peacefully 18 hours later, meeting his EOL goals, and the family was empowered to provide effective care for the patient at home. The family found the intervention easy to use. This case demonstrates how this new innovation can be used to ensure rapid symptom management and decreased burden of care by facilitating immediate and easy use of medications already present in the home.

[1]  D. McGuire,et al.  Pain Assessment in Noncommunicative Adult Palliative Care Patients. , 2016, The Nursing clinics of North America.

[2]  B. Macy,et al.  Pharmacokinetics of Phenobarbital in Microenema Via Macy Catheter Versus Suppository. , 2016, Journal of pain and symptom management.

[3]  E. Kulstad,et al.  First Use of a New Device for Administration of Buspirone and Acetaminophen to Suppress Shivering During Therapeutic Hypothermia , 2016, Therapeutic hypothermia and temperature management.

[4]  Marc McDowell,et al.  An alternative for rapid administration of medication and fluids in the emergency setting using a novel device. , 2015, The American journal of emergency medicine.

[5]  Jennifer A Kowalkowski,et al.  A Systematic Review of the Prevalence of Signs of Impending Death and Symptoms in the Last 2 Weeks of Life , 2013, The American journal of hospice & palliative care.

[6]  I. Higginson,et al.  Heterogeneity and changes in preferences for dying at home: a systematic review , 2013, BMC Palliative Care.

[7]  D. McGuire,et al.  Measuring Pain in Non-Communicative Patients in the Inpatient Hospice Setting: Psychometric Evaluation of the Multidimensional Objective Pain Assessment Tool (MOPAT) (SA517-A) , 2013 .

[8]  D. Wilkie,et al.  Pain and symptom management in palliative care and at end of life. , 2012, Nursing outlook.

[9]  Thomas J. Smith,et al.  ABH gel is not absorbed from the skin of normal volunteers. , 2012, Journal of pain and symptom management.

[10]  D. McGuire,et al.  Assessing pain in nonresponsive hospice patients: development and preliminary testing of the multidimensional objective pain assessment tool (MOPAT). , 2011, Journal of palliative medicine.

[11]  G. Wilson,et al.  Rational use of sublingual opioids in palliative medicine. , 2007, Journal of palliative medicine.

[12]  Mellar P. Davis,et al.  Symptom control in cancer patients: the clinical pharmacology and therapeutic role of suppositories and rectal suspensions , 2002, Supportive Care in Cancer.

[13]  M. Letizia,et al.  Intermittent subcutaneous injections of pain medication: Effectiveness, manageability, and satisfaction , 1999, The American journal of hospice & palliative care.

[14]  D. E. Warren Practical use of rectal medications in palliative care. , 1996, Journal of pain and symptom management.

[15]  R. A. Crane Intermittent subcutaneous infusion of opioids in hospice home care: An effective, economical, manageable option , 1994, The American journal of hospice & palliative care.

[16]  D. Breimer,et al.  Pharmacokinetics of Rectal Drug Administration, Part I , 1991, Clinical pharmacokinetics.

[17]  K. Foley,et al.  Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. , 1990, Journal of pain and symptom management.

[18]  K. Foley,et al.  Sublingual absorption of selected opioid analgesics , 1988, Clinical pharmacology and therapeutics.

[19]  D. Breimer,et al.  Rectal Drug Administration , 1982, Clinical pharmacokinetics.

[20]  D. McGuire,et al.  Pain Assessment in Non-Communicative Adult Palliative Care Patients , 2016 .

[21]  Pall Med,et al.  Dying in America: improving quality and honoring individual preferences near the end of life. , 2015, Military medicine.

[22]  N. Narang,et al.  SUBLINGUAL MUCOSA AS A ROUTE FOR SYSTEMIC DRUG DELIVERY , 2011 .

[23]  D. McGuire,et al.  Measuring Pain in Noncommunicative Palliative Care Patients in the Acute Care Setting: Psychometric Evaluation of the Multidimensional Objective Pain Assessment Tool (MOPAT) (745) , 2011 .

[24]  T. Voepel-Lewis,et al.  Reliability and validity of the face, legs, activity, cry, consolability behavioral tool in assessing acute pain in critically ill patients. , 2010, American journal of critical care : an official publication, American Association of Critical-Care Nurses.